Daniela Merlotti Selected Research

Osteitis Deformans (Paget's Disease of Bone)

1/2021	Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders.
1/2020	Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease.
10/2019	Vitamin D Status in Paget Disease of Bone and Efficacy-Safety Profile of Cholecalciferol Treatment in Pagetic Patients with Hypovitaminosis D.
8/2018	Interleukin-6 trans-signaling and pathological low back pain in patients with Paget disease of bone.
7/2014	Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function.
3/2011	Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone.
12/2008	Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone.
10/2007	Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Merlotti Research Topics

Disease

16	Osteoporosis 01/2021 - 06/2004
8	Osteitis Deformans (Paget's Disease of Bone) 01/2021 - 10/2007
6	Breast Neoplasms (Breast Cancer) 04/2012 - 01/2007
5	Postmenopausal Osteoporosis 02/2011 - 01/2007
4	Bone Resorption 02/2022 - 04/2008
4	Hypertension (High Blood Pressure) 06/2021 - 06/2015
4	Pain (Aches) 01/2020 - 01/2009
4	Neoplasms (Cancer) 02/2015 - 01/2007
4	Atrophy 02/2011 - 06/2009
3	Vitamin D Deficiency 01/2020 - 03/2009
2	COVID-19 06/2021 - 01/2021
2	Infections 01/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 10/2019
2	Congenital Abnormalities (Deformity) 02/2013 - 01/2009
2	Endometrial Neoplasms (Endometrial Cancer) 02/2011 - 06/2010
2	Osteoporotic Fractures 02/2011 - 06/2010
1	Chronic Disease (Chronic Diseases) 02/2022
1	Dysbiosis 02/2022
1	Obesity 06/2021
1	Bone Fractures (Bone Fracture) 01/2021
1	Epilepsy (Aura) 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Acute-Phase Reaction 01/2020
1	Nephrolithiasis 10/2019
1	Cushing Syndrome 10/2019
1	Low Back Pain (Lumbago) 08/2018
1	Essential Hypertension 06/2015
1	Giant Cell Tumors (Giant Cell Tumor) 02/2013
1	Diabetes Mellitus 01/2013
1	Hip Fractures (Intertrochanteric Fractures) 05/2010
1	Osteomalacia 03/2009
1	Smoldering Multiple Myeloma 04/2008
1	Thyroid Neoplasms (Thyroid Cancer) 04/2008
1	Osteolysis 04/2008
1	Multiple Myeloma 04/2008
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2007

Drug/Important Bio-Agent (IBA)

9	Diphosphonates (Bisphosphonates)IBA 01/2021 - 10/2007
7	Selective Estrogen Receptor Modulators (SERM)IBA 04/2012 - 09/2006
6	Vitamin D FDA LinkGeneric 06/2021 - 03/2009
5	Estrogens (Estrogen)FDA Link 02/2022 - 06/2004
5	LasofoxifeneIBA 02/2011 - 09/2006
4	Raloxifene Hydrochloride (Evista)FDA Link 02/2011 - 01/2007
3	CalciumIBA 02/2022 - 04/2007
3	25-hydroxyvitamin DIBA 01/2021 - 06/2015
3	GlucocorticoidsIBA 04/2020 - 10/2019
3	Pharmaceutical PreparationsIBA 01/2015 - 05/2010
3	Hormones (Hormone)IBA 06/2009 - 01/2007
2	Interleukin-6 (Interleukin 6)IBA 06/2021 - 08/2018
2	Zoledronic Acid (Zometa)FDA Link 01/2020 - 04/2008
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020 - 10/2019
2	Cholecalciferol (Vitamin D3)FDA Link 10/2019 - 06/2015
2	Biological ProductsIBA 08/2018 - 04/2007
2	Alkaline PhosphataseIBA 02/2015 - 01/2009
2	Toremifene (Fareston)FDA Link 04/2012 - 01/2007
2	Estrogen ReceptorsIBA 04/2012 - 02/2010
2	Progestins (Progestagens)IBA 02/2011 - 06/2010
2	OspemifeneIBA 06/2009 - 01/2007
2	Calcitriol Receptors (Calcitriol Receptor)IBA 03/2009 - 12/2008
2	NitrogenIBA 01/2009 - 04/2008
2	bazedoxifeneIBA 12/2008 - 01/2007
2	Tamoxifen FDA LinkGeneric 05/2008 - 01/2007
2	LipidsIBA 04/2008 - 01/2007
1	VitaminsIBA 02/2022
1	CreatinineIBA 06/2021
1	C-Reactive ProteinIBA 06/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2021
1	LDL CholesterolIBA 01/2021
1	GhrelinIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	CholesterolIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	AntibodiesIBA 01/2021
1	AntipyreticsIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	InterleukinsIBA 08/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 06/2016
1	Denosumab FDA Link 06/2016
1	Antihypertensive Agents (Antihypertensives)IBA 06/2015
1	MineralsIBA 06/2015
1	Anabolic AgentsIBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 07/2014
1	UbiquitinIBA 07/2014
1	IncretinsIBA 01/2013
1	Bone Density Conservation AgentsIBA 04/2012
1	AndrogensIBA 04/2012
1	6- amino- 1- hydroxyhexane- 1,1- diphosphonateIBA 03/2011
1	LubricantsIBA 06/2009
1	Clodronic Acid (Clodronate)IBA 12/2008
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2008

Therapy/Procedure

8	Therapeutics 01/2013 - 01/2007
2	Drug Therapy (Chemotherapy) 01/2020 - 06/2016
2	Estrogen Replacement Therapy 06/2016 - 02/2011
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2010 - 01/2007
1	Ketogenic Diet 01/2021
1	Glycemic Control 01/2013